* Chimerix Inc CMRX.OQ CMRX.O is expected to show a fall
in
quarterly revenue when it reports results
* The Durham North Carolina-based company is expected to
report
a 99.8% decrease in revenue to $76.43 thousand from $32.56
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Chimerix Inc is for
a
loss of 23 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Chimerix
Inc is
$7, above its last closing price of $0.96.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.23 -0.24 -0.21 Beat 13.8
Mar. 31 2023 -0.25 -0.25 -0.24 Beat 4.1
Dec. 31 2022 -0.24 -0.24 -0.24 Met -1.4
Sep. 30 2022 2.13 2.14 2.75 Beat 28.6
Jun. -0.25 -0.24 -0.27 Missed -11.6
30 2022
Mar. 31 2022 -0.33 -0.33 -0.28 Beat 15.6
Dec. 31 2021 -0.32 -0.17 -0.45 Missed -157.1
Sep. 30 2021 -0.14 -0.15 -0.21 Missed -40.6
This summary was machine generated October 31 at 18:55 GMT. All
figures in US dollars unless otherwise stated